Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non ‐small cell lung cancer
ConclusionCombing chemotherapy with ICIs improved treatment efficacy over ICIs alone. The additional efficacy of chemotherapy may differ between histological subtypes andEGFR mutation status.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Chih ‐Hsi Scott Kuo,
Chin‐Chou Wang,
Yu‐Chen Huang,
Stelios Pavlidis,
Chien‐Ying Liu,
How‐Wen Ko,
Fu‐Tsai Chung,
Tin‐Yu Lin,
Chih‐Liang Wang,
Yi‐Ke Guo,
Cheng‐Ta Yang Tags: ORIGINAL ARTICLE Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | China Health | Lung Cancer | Non-Small Cell Lung Cancer